Noting “222 million women have an unmet need for modern contraceptive methods” and summarizing some of the reasons for this lack of access, Judy Manning, health development officer with USAID’s Office of Population and Reproductive Health, and Zeda Rosenberg, CEO of the International Partnership for Microbicides, write in the Carnegie Council’s “Policy Innovations” blog, “New sexual and reproductive health innovations have the potential to revolutionize women’s options by diversifying delivery forms, varying product duration, and targeting multiple health risks simultaneously.” They continue, “We are excited about a number of cutting-edge technologies now in development,” and they describe several research projects, focusing on “multipurpose prevention technologies (MPTs) [that] can help address women’s overlapping health needs in a single product.” They conclude, “New tools are not developed overnight — they take time, effort, and dedicated resources. But it is an investment that will help make modern contraception a reality for the millions of women whose lives and well-being depend on it” (9/26).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.